These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
294 related articles for article (PubMed ID: 28579122)
21. Design and evaluation of non-carboxylate 5-arylidene-2-thioxo-4-imidazolidinones as novel non-competitive inhibitors of protein tyrosine phosphatase 1B. Ottanà R; Paoli P; Lori G; Adornato I; Previti S; Naß A; Wolber G; Maccari R Bioorg Chem; 2019 Nov; 92():103211. PubMed ID: 31491569 [TBL] [Abstract][Full Text] [Related]
22. Novel Imbricatolic acid derivatives as protein tyrosine phosphatase-1B inhibitors: Design, synthesis, biological evaluation and molecular docking. Khan MF; Azad CS; Kumar A; Saini M; Narula AK; Jain S Bioorg Med Chem Lett; 2016 Apr; 26(8):1988-92. PubMed ID: 26965864 [TBL] [Abstract][Full Text] [Related]
23. Discovery of 2-ethoxy-4-(methoxymethyl)benzamide derivatives as potent and selective PTP1B inhibitors. Xie F; Liang Y; Xia Y; Luo S; Jiang F; Fu L Bioorg Chem; 2019 Nov; 92():103273. PubMed ID: 31539748 [TBL] [Abstract][Full Text] [Related]
24. Discovery of 1,3-diphenyl-1H-pyrazole derivatives containing rhodanine-3-alkanoic acid groups as potential PTP1B inhibitors. Sun L; Wang P; Xu L; Gao L; Li J; Piao H Bioorg Med Chem Lett; 2019 May; 29(10):1187-1193. PubMed ID: 30910462 [TBL] [Abstract][Full Text] [Related]
25. Design, synthesis, molecular docking and in silico ADMET profile of pyrano[2,3-d]pyrimidine derivatives as antimicrobial and anticancer agents. Abd El-Sattar NEA; El-Adl K; El-Hashash MA; Salama SA; Elhady MM Bioorg Chem; 2021 Oct; 115():105186. PubMed ID: 34314914 [TBL] [Abstract][Full Text] [Related]
26. Design and synthesis of new potent PTP1B inhibitors with the skeleton of 2-substituted imino-3-substituted-5-heteroarylidene-1,3-thiazolidine-4-one: Part I. Meng G; Zheng M; Wang M; Tong J; Ge W; Zhang J; Zheng A; Li J; Gao L; Li J Eur J Med Chem; 2016 Oct; 122():756-769. PubMed ID: 27526040 [TBL] [Abstract][Full Text] [Related]
27. Design, synthesis, molecular docking and cytotoxic evaluation of novel 2-furybenzimidazoles as VEGFR-2 inhibitors. Abdullaziz MA; Abdel-Mohsen HT; El Kerdawy AM; Ragab FAF; Ali MM; Abu-Bakr SM; Girgis AS; El Diwani HI Eur J Med Chem; 2017 Aug; 136():315-329. PubMed ID: 28505536 [TBL] [Abstract][Full Text] [Related]
28. Canthinone alkaloids are novel protein tyrosine phosphatase 1B inhibitors. Sasaki T; Li W; Higai K; Koike K Bioorg Med Chem Lett; 2015 May; 25(9):1979-81. PubMed ID: 25819098 [TBL] [Abstract][Full Text] [Related]
29. Synthesis and biological evaluation of novel thiadiazole amides as potent Cdc25B and PTP1B inhibitors. Li Y; Yu Y; Jin K; Gao L; Luo T; Sheng L; Shao X; Li J Bioorg Med Chem Lett; 2014 Sep; 24(17):4125-8. PubMed ID: 25124112 [TBL] [Abstract][Full Text] [Related]
30. Discovery of potent PTP1B inhibitors via structure-based drug design, synthesis and in vitro bioassay of Norathyriol derivatives. Xue W; Tian J; Wang XS; Xia J; Wu S Bioorg Chem; 2019 May; 86():224-234. PubMed ID: 30716620 [TBL] [Abstract][Full Text] [Related]
31. Design, synthesis, and biological evaluation of bromophenol derivatives as protein tyrosine phosphatase 1B inhibitors. Jiang B; Shi D; Cui Y; Guo S Arch Pharm (Weinheim); 2012 Jun; 345(6):444-53. PubMed ID: 22307562 [TBL] [Abstract][Full Text] [Related]
32. Protein tyrosine phosphatase 1B and α-glucosidase inhibitory activities of Pueraria lobata root and its constituents. Seong SH; Roy A; Jung HA; Jung HJ; Choi JS J Ethnopharmacol; 2016 Dec; 194():706-716. PubMed ID: 27769948 [TBL] [Abstract][Full Text] [Related]
33. Eco-friendly synthesis of novel cyanopyridine derivatives and their anticancer and PIM-1 kinase inhibitory activities. Abouzid KAM; Al-Ansary GH; El-Naggar AM Eur J Med Chem; 2017 Jul; 134():357-365. PubMed ID: 28431341 [TBL] [Abstract][Full Text] [Related]
34. Design, synthesis, and molecular docking studies of 2-(furan-2-yl)quinazolin-4-one derivatives as potential antiproliferative agents. Ahmed MF; Belal A Arch Pharm (Weinheim); 2015 Jul; 348(7):487-97. PubMed ID: 25921702 [TBL] [Abstract][Full Text] [Related]
35. Trivaric acid, a new inhibitor of PTP1b with potent beneficial effect on diabetes. Sun W; Zhang B; Zheng H; Zhuang C; Li X; Lu X; Quan C; Dong Y; Zheng Z; Xiu Z Life Sci; 2017 Jan; 169():52-64. PubMed ID: 27871946 [TBL] [Abstract][Full Text] [Related]
36. Design, Synthesis and Biological Evaluation of Stilbene Derivatives as Novel Inhibitors of Protein Tyrosine Phosphatase 1B. He H; Ge Y; Dai H; Cui S; Ye F; Jin J; Shi Y Molecules; 2016 Dec; 21(12):. PubMed ID: 27999292 [TBL] [Abstract][Full Text] [Related]
37. Synthesis and characterization of 5,7-dihydroxyflavanone derivatives as novel protein tyrosine phosphatase 1B inhibitors. Sun LP; Ma WP; Gao LX; Yang LL; Quan YC; Li J; Piao HR J Enzyme Inhib Med Chem; 2013 Dec; 28(6):1199-204. PubMed ID: 23009604 [TBL] [Abstract][Full Text] [Related]
38. Synthesis, biological evaluation and 3D-QSAR studies of imidazolidine-2,4-dione derivatives as novel protein tyrosine phosphatase 1B inhibitors. Wang MY; Jin YY; Wei HY; Zhang LS; Sun SX; Chen XB; Dong WL; Xu WR; Cheng XC; Wang RL Eur J Med Chem; 2015 Oct; 103():91-104. PubMed ID: 26342135 [TBL] [Abstract][Full Text] [Related]
39. Design, Synthesis and Anticancer Evaluation of New Substituted Thiophene-Quinoline Derivatives. Othman DIA; Selim KB; El-Sayed MA; Tantawy AS; Amen Y; Shimizu K; Okauchi T; Kitamura M Bioorg Med Chem; 2019 Oct; 27(19):115026. PubMed ID: 31416740 [TBL] [Abstract][Full Text] [Related]
40. Design, synthesis of novel azolyl flavonoids and their protein tyrosine Phosphatase-1B inhibitory activities. Zhang L; Ge Y; Song HM; Wang QM; Zhou CH Bioorg Chem; 2018 Oct; 80():195-203. PubMed ID: 29940341 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]